Skip to Content
Fund Spy: Morningstar Medalist Edition

More Winners and Losers Among Funds With Morningstar Analyst Ratings

A look at a few unusual performance and sales patterns among our Morningstar Medalists.

Mentioned: , , , , , , , , ,

'Tis the season for summing up. My colleague Russel Kinnel recently listed 2014's mutual fund winners and losers, and the annual Morningstar Fund Manager of the Year awards are in the works. We've already written about some of the contenders for the domestic and international stock, fixed-income, allocation, and alternative prizes and will announce the finalists and winners in January. Until then, here are some other less-obvious observations on the 2014 performance and fund flows of some of the more than 1,000 funds with Morningstar Analyst Ratings.

Best Equity Fund Performance by a Non-India, Non-Real-Estate, Non-Health-Care, Non-Primecap-Run Fund
Bronze-rated  Matthews India (MINDX) was the best-performing rated equity fund with a 60% gain through Dec. 18 on the back of a gigantic Indian stock market rally. The real estate and health-care sectors enjoyed strong rallies, too, with Bronze-rated  Nuveen Real Estate Securities (FARCX) and Gold-rated  Vanguard Health Care (VGHCX) showing up a bit behind with still-impressive gains of around 30% each.

To view this article, become a Morningstar Basic member.

Register for Free

Dan Culloton has a position in the following securities mentioned above: VGHCX, DODFX, PTTRX, VFINX. Find out about Morningstar’s editorial policies.